The record
| Class | melanocortin |
|---|---|
| Also known as | - |
| Chain length | - |
| Molecular weight | 1,024.2 Da |
| Half-life | 33 hours |
| Route | - |
| Studied for | - |
| Research use | - |
| What has been shown | - |
| How it works | MC1R - melanogenesis; MC4R - sexual arousal; MC3R - appetite suppression |
| Patent status | - |
| Regulatory status | - |
Blank = not established in the record. Nothing is estimated to fill a gap.
Where it is matched
- Appetite Regulation Environment (affection, 56%)
- Melanocortin Pathway Signaling (affection, 100%)
- Erythropoietic protoporphyria - FDA approved (illness, 30%)
- FDA-approved for hypoactive sexual desire disorder in premenopausal women (illness, 60%)
- Polymorphous light eruption (illness, 30%)
- Solar urticaria (illness, 30%)
- Vitiligo (illness, 30%)
- Low libido (symptom, 50%)